Gilead Sciences, Inc. (GILD): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$5.41B
As of 2022-12-31
-22.5%
3-year compound annual growth
-6.5%
5-year compound annual growth
+11.6%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $5.41B | +1.4% | 2023-02-22, Balance as of period end |
| 2021-12-31 | $5.34B | -11.0% | 2023-02-22, Balance as of period end |
| 2020-12-31 | $6.00B | -48.4% | 2022-02-23, Balance as of period end |
| 2019-12-31 | $11.63B | -35.2% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $17.94B | +136.4% | 2020-02-25, Balance as of period end |
| 2017-12-31 | $7.59B | -7.8% | 2019-02-26, Balance as of period end |
| 2016-12-31 | $8.23B | -36.0% | 2019-02-26, Balance as of period end |
| 2015-12-31 | $12.85B | +28.2% | 2018-02-27, Balance as of period end |
| 2014-12-31 | $10.03B | +374.5% | 2017-02-27, Balance as of period end |
| 2013-12-31 | $2.11B | +17.1% | 2016-02-24, Balance as of period end |
| 2012-12-31 | $1.80B | -81.7% | 2015-02-25, Balance as of period end |
| 2011-12-31 | $9.88B | +988.7% | 2014-02-25, Balance as of period end |
| 2010-12-31 | $907.88M | -28.7% | 2013-02-27, Balance as of period end |
| 2009-12-31 | $1.27B | -12.8% | 2012-02-23, Balance as of period end |
| 2008-12-31 | $1.46B | +50.7% | 2011-02-28, Balance as of period end |
| 2007-12-31 | $968.09M | n/a | 2010-03-01, Balance as of period end |